Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
Search
2025 AM Best Rate Revision
AM Best has revised the outlooks to positive from stable and affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and the long-term issuer credit rating (ICR) of "a+”. The positive outlooks, FSR of A, and long-term ICR of “a+” have been affirmed for The Doctors Company, an Interinsurance Exchange, and its core subsidiaries, which collectively comprise The Doctors Company Insurance Group (TDC or TDC Group).
Nov 27, 2023
Continuing Education: Essential Risk Management for Healthcare Professionals
Our complimentary on demand course focuses on the legal elements of a malpractice claim and offers tips to help you demonstrate quality of care and reduce risk.
From
The Doctor’s Advocate
NYRSPS Partnership
The New York Regional Society of Plastic Surgeons (NYRSPS) has chosen The Doctors Company, part of TDC Group, as the exclusively endorsed medical malpractice insurer for its members.
April 04, 2024, KevinMD
Rise of Mega Payouts: Physicians Are Now the White Whales
Robert White, President of The Doctors Company and TDC Group, discusses the unexpected emergence of nuclear verdicts in states where they were once considered rare.
January 30, 2024, MDLinx
A Georgia Man's Failed Heart Transplant Culminates In a $38.6M Malpractice Verdict Against Emory Healthcare
Robert White, President of The Doctors Company and TDC Group, discusses some of the causes of the rise in high-dollar medical malpractice verdicts.
February 08, 2024, Becker's ASC Review
Malpractice Mega-Verdicts Hit Record High
Robert White, President of The Doctors Company and TDC Group, discusses how a rollback of tort reform could be a factor in the rise of nuclear malpractice verdicts.
The Doctors Company Announces $8.5 Million Member Dividend
We are proud to announce The Doctors Company has approved a 2023 premium dividend of approximately $8.5 million, bringing the total of declared dividends to date to more than $455 million.
Cost and Impact of Defensive Medicine
Physicians practice defensive medicine all the time—some acknowledge and accept it, while others believe it is untrue and unconscionable. The Doctors Company CEO and Chairman Richard E. Anderson, MD, FACP, examines the pervasive nature of defensive medicine in this article.
Professional Education
Healthcare AI: Peril or Paradigm?
This program provides nurses with an overview of the range of artificial intelligence models that can potentially be applied in healthcare, examples of regulatory and ethical AI guidance documents, and evidence-based discussions of risks and strategies to address the risks of using AI in healthcare.
